| 220.86 Delayed Data As of Nov 15 |  +2.36 / +1.08%Today’s Change | 166.30 Today|||52-Week Range 225.26 | +13.45% Year-to-Date |
| Amarin's Stock Could Reach $50 Per Share Soon Nov 13 / MotleyFool.com - Paid Partner Content | 3 Cancer Treatment Stocks to Buy Right Now Nov 09 / MotleyFool.com - Paid Partner Content |
| Here’s Why FibroGen’s Stock Popped Friday Nov 11 / MotleyFool.com - Paid Partner Content | Here's Why Cytokinetics Stock Tanked on Thursday Nov 07 / MotleyFool.com - Paid Partner Content |
| Why Amgen's Stock Soared in October Nov 11 / MotleyFool.com - Paid Partner Content | Buy These 2 Stocks to Access China's Huge Healthcare Market Nov 06 / MotleyFool.com - Paid Partner Content |
| Previous close | 218.50 |
| Today’s open | 219.59 |
| Day’s range | 217.21 - 220.93 |
| Volume | 2,028,585 |
| Average volume (3 months) | 2,831,902 |
| Market cap | -- |
| Earnings growth (last year) | +368.59% |
| Earnings growth (this year) | +0.15% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | +4.32% |
| P/E ratio | 17.0 |
| Price/Sales | 5.45 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | +1.26 | +1.97% |
| BIIBBiogen | +7.12 | +2.59% |
| ILMNIllumina Inc | +7.55 | +2.53% |
| BMRNBiomarin Pharmaceuti... | -0.54 | -0.71% |
| Next reporting date | January 30, 2020 |
| EPS forecast (this quarter) | $3.25 |
| Annual revenue (last year) | $23.8B |
| Annual profit (last year) | $8.4B |
| Net profit margin | 35.32% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
